science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0106072 on August 3, 2006

Published online before print August 3, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0106072v1
80/4/880    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vendetti, S.
Right arrow Articles by De Magistris, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vendetti, S.
Right arrow Articles by De Magistris, M. T.
(Journal of Leukocyte Biology. 2006;80:880-888.)
© 2006 by Society for Leukocyte Biology

Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP

Silvia Vendetti*,1, Mario Patrizio{dagger}, Antonella Riccomi* and Maria Teresa De Magistris*

Departments of
* Infectious, Parasitic and Immune-Mediated Diseases and
{dagger} Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy

1 Correspondence: Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy. E-mail: vendetti{at}iss.it

We have previously shown that cholera toxin (CT) and other cAMP-elevating agents induce up-regulation of the inhibitory molecule CTLA-4 on human resting T lymphocytes. In this study, we evaluated the function of these cells. We found that purified human CD4+ T lymphocytes pretreated with CT were able to inhibit proliferation of autologous PBMC in a dose-dependent manner. It is interesting that this phenomenon was not mediated by inhibitory cytokines such as IL-10, IL-4, or TGF-ß but was in part caused by the release of extracellular cAMP by the CD4+ T lymphocytes. Purified CD4+ T cells pretreated with forskolin, a transient cAMP inducer, or with dibutyryl cAMP, an analog of cAMP, did not exert suppressive functions, suggesting that a sustained production of cAMP, such as that induced by CT, was required to identify a novel regulatory function mediated by CD4+ T cells. Our results show that CD4+ T lymphocytes can exert regulatory functions through the release of extracellular cAMP and that the cyclic nucleotide acts as a primary messenger, which could play a biological role in the modulation of immune responses.

Key Words: T cells • suppression • cholera toxin • immunoregulation




This article has been cited by other articles:


Home page
Infect. Immun.Home page
D. R. M. Negri, D. Pinto, S. Vendetti, M. Patrizio, M. Sanchez, A. Riccomi, P. Ruggiero, G. Del Giudice, and M. T. De Magistris
Cholera Toxin and Escherichia coli Heat-Labile Enterotoxin, but Not Their Nontoxic Counterparts, Improve the Antigen-Presenting Cell Function of Human B Lymphocytes
Infect. Immun., May 1, 2009; 77(5): 1924 - 1935.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
A. M. Hofer and K. Lefkimmiatis
Extracellular Calcium and cAMP: Second Messengers as "Third Messengers"?
Physiology, October 1, 2007; 22(5): 320 - 327.
[Abstract] [Full Text] [PDF]